Boston Scientific Subsidiary to Pay $9.25M to Resolve Claims of Inflated Defibrillator Costs

Guidant, a subsidiary of Natick, Mass.-based Boston Scientific, has agreed to pay $9.25 million to settle False Claims Act charges over the company's alleged cost inflation for pacemakers and defibrillators, according to a news release from the Department of Justice.

Read more at Becker's ASC Review.